Current Evidence of Interleukin-6 Signaling Inhibitors in Patients With COVID-19: A Systematic Review and Meta-Analysis.

Han, Qi; Guo, Mingyue; Zheng, Yue; Zhang, Ying; De, Yanshan; Xu, Changchang; Zhang, Lin; Sun, Ruru; Lv, Ying; Liang, Yan; Xu, Feng; Pang, Jiaojiao; Chen, Yuguo

Han, Qi; Guo, Mingyue; Zheng, Yue; Zhang, Ying; De, Yanshan; Xu, Changchang; Zhang, Lin; Sun, Ruru; Lv, Ying; Liang, Yan; Xu, Feng; Pang, Jiaojiao; Chen, Yuguo.

Afiliação

Han Q; Department of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China.
Guo M; Shandong Provincial Clinical Research Center for Emergency and Critical Care Medicine, Institute of Emergency and Critical Care Medicine of Shandong University, Chest Pain Center, Qilu Hospital of Shandong University, Jinan, China.
Zheng Y; Key Laboratory of Emergency and Critical Care Medicine of Shandong Province, Key Laboratory of Cardiopulmonary-Cerebral Resuscitation Research of Shandong Province, Shandong Provincial Engineering Laboratory for Emergency and Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, China
Zhang Y; The Key Laboratory of Cardiovascular Remodeling and Function Research, The State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Chinese Ministry of Education, Chinese Ministry of Health and Chinese Academy of Medical Sciences, Qilu Hospital of Shandong Universit
De Y; Department of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China.
Xu C; Shandong Provincial Clinical Research Center for Emergency and Critical Care Medicine, Institute of Emergency and Critical Care Medicine of Shandong University, Chest Pain Center, Qilu Hospital of Shandong University, Jinan, China.
Zhang L; Key Laboratory of Emergency and Critical Care Medicine of Shandong Province, Key Laboratory of Cardiopulmonary-Cerebral Resuscitation Research of Shandong Province, Shandong Provincial Engineering Laboratory for Emergency and Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, China
Sun R; The Key Laboratory of Cardiovascular Remodeling and Function Research, The State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Chinese Ministry of Education, Chinese Ministry of Health and Chinese Academy of Medical Sciences, Qilu Hospital of Shandong Universit
Lv Y; Department of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China.
Liang Y; Shandong Provincial Clinical Research Center for Emergency and Critical Care Medicine, Institute of Emergency and Critical Care Medicine of Shandong University, Chest Pain Center, Qilu Hospital of Shandong University, Jinan, China.
Xu F; Key Laboratory of Emergency and Critical Care Medicine of Shandong Province, Key Laboratory of Cardiopulmonary-Cerebral Resuscitation Research of Shandong Province, Shandong Provincial Engineering Laboratory for Emergency and Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, China
Pang J; The Key Laboratory of Cardiovascular Remodeling and Function Research, The State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Chinese Ministry of Education, Chinese Ministry of Health and Chinese Academy of Medical Sciences, Qilu Hospital of Shandong Universit
Chen Y; Department of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China.

Front Pharmacol ; 11: 615972, 2020.

Article em En | MEDLINE | ID: mdl-33384605

Palavras-chave

COVID-19; ICU admission; anti-IL-6 signaling agents; clinical improvement; mechanical ventilation; mortality; secondary infections

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Idioma: En Revista: Front Pharmacol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google